Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05121168Phase 4Completed
Phase 4, randomised, triple-blind trial of bupivacaine in acute postoperative pain (2 arms), sponsored by University of California, San Diego. Primary endpoints: Mean of the 'Average' Pain at Rest on Postoperative Days 1 and 2 at Day 2 and Total Opioid Consumption From Recovery Room Discharge Until Postoperative Day 2. Started Mar 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05121168.